Tubulis raised €308 million in a Series C funding round co-led by Venrock, Wellington Management, and Ascenta Capital,

Biotech Health services

Investments

03 October 2025

Tubulis (company)

Biotech Health services

Total investments received (USD): N/A

Round value (USD): 361.28m

Round investors: Andera Partners Bayern Kapital EQT Partners Fundplus High-Tech Gründerfonds Mutua Madrileña OCCIDENT Seventure Partners Venrock Wellington Management Deep Track Capital Nextech Invest Frazier Life Sciences Ascenta Capital

Company: Tubulis

Industry: Biotech Health services

Related deals

Tubulis in germany was acquired by Nasdaq-listed Gilead Sciences for $5 billion, $315B upfront, plus up to $1.85B in contingent milestone payments.

Biotech Health services

MA 01 April 2026

Menu

Tubulis raised €308 million in a Series C funding round co-led by Venrock, Wellington Management, and Ascenta Capital,

Share:

Tubulis (company)

Related deals

Tubulis in germany was acquired by Nasdaq-listed Gilead Sciences for $5 billion, $315B upfront, plus up to $1.85B in contingent milestone payments.

Sidebar

Verticals

Benelux

DACH

Nordics and Baltics

Western Europe